Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy

计划入组 40 人 · 首次发布于 2010 年 6 月 7 日

Kaletra Sex/Gender Pharmacokinetics (PK) Study

计划入组 23 人 · 首次发布于 2005 年 9 月 8 日

Lopinavir/Ritonavir Monotherapy in Children

计划入组 40 人 · 首次发布于 2008 年 2 月 29 日

Lopinavir(Kaletra, Lopinavir/Ritonavir Viatris (previously Ritonavir Mylan))

C₃₇H₄₈N₄O₅ · Rx

Long Peptide Vaccine LPV7

(R,R')-penehyclidine fumarate

R&R, Inc.

United States

Anabio R&D

Vietnam

R-Biopharm AG

Germany

New Study Shows TAF and Dolutegravir Superior for Second-Line HIV Treatment in Children

HIV Drug Resistance Declining in South Africa, but Integrase Inhibitor Resistance Requires Vigilance

P-BCMA-ALLO1 Demonstrates Promising Efficacy and Safety in Relapsed/Refractory Multiple Myeloma